Luceiro Capital Companies

ESEN

Real companies with freely usable public data: official annual reports of European listed companies (ESEF), SEC accounts and ECB exchange rates. No share prices, so there is no market capitalisation, P/E or EV/EBITDA.

Company sheet · analysis as of 21/10/2026

MetLife, Inc.

MET · Financials · Insurance · US · reporting currency USD · LEI C4BXATY60WC6XEOZDX54

Share: XNYS · USD · US59156R1086 · Price: No data: no share prices up to the analysis date

Reference period: H1 ended 30/06/2026, published on 06/08/2026

← Back to the ranking

Shareholder score without valuation

Not available

Coverage 100 % · Only 2 factors with data (minimum 3)

Credit score

Not available

Coverage 0 % · No factor applies to this company

Alerts

0

Screens passed: 0 of 1

Shareholder view

FactorValueCompared with PercentileWeightContribution
ROE 13.2 % Sector (6 companies) 42 17 % —
ROIC Not applicable — — 17 % —
Not applicable to banks and insurers: their EBITDA, debt and enterprise value are not comparable with those of a non-financial company.
Gross margin Not applicable — — 17 % —
Not applicable to banks and insurers: their EBITDA, debt and enterprise value are not comparable with those of a non-financial company.
EBITDA margin Not applicable — — 17 % —
Not applicable to banks and insurers: their EBITDA, debt and enterprise value are not comparable with those of a non-financial company.
Cash conversion Not applicable — — 17 % —
Not applicable to banks and insurers: their EBITDA, debt and enterprise value are not comparable with those of a non-financial company.
Revenue growth 8.7 % Sector (8 companies) 81 17 % —
Formulas and inputs

ROE: LTM attributable net income / Attributable equity at period end

LTM attributable net income
3,626.0
Attributable equity
27,441.0

ROIC: LTM EBIT × (1 − notional tax rate) / (Total equity + Financial debt − Cash)

Gross margin: LTM gross profit / LTM revenue

EBITDA margin: LTM EBITDA / LTM revenue

Cash conversion: (LTM operating cash flow − LTM capex) / LTM net income attributable

Revenue growth: LTM revenue / LTM revenue a year earlier − 1

LTM revenue
79,403.0
Prior-year LTM revenue
73,015.0

Amounts in euros

Market capitalisation No data
Enterprise value (EV) Not applicable
LTM revenue 68,088 M EUR
LTM EBITDA Not applicable
Net debt Not applicable

Creditor view

FactorValueCompared with PercentileWeightContribution
Net debt/EBITDA Not applicable — — 33 % —
Not applicable to banks and insurers: their EBITDA, debt and enterprise value are not comparable with those of a non-financial company.
Interest coverage Not applicable — — 33 % —
Not applicable to banks and insurers: their EBITDA, debt and enterprise value are not comparable with those of a non-financial company.
Debt/equity Not applicable — — 33 % —
Not applicable to banks and insurers: their debt includes deposits and the funding of their business, and their solvency is measured with capital ratios.
Formulas and inputs

Net debt/EBITDA: (Financial debt − Cash) / LTM EBITDA

Interest coverage: LTM EBITDA / LTM interest expense

Debt/equity: Financial debt / Total equity

Outstanding bonds

The loaded data contain no outstanding bonds of this company.

Alerts

No alerts in this run.

Screens

ScreenResultConditions
Moderate leverage Undetermined Net debt/EBITDA ≤ 2.5x: Not applicable: Not applicable to banks and insurers: their EBITDA, debt and enterprise value are not comparable with those of a non-financial company.
Interest coverage ≥ 5.0x: Not applicable: Not applicable to banks and insurers: their EBITDA, debt and enterprise value are not comparable with those of a non-financial company.

Annual history (millions of USD)

2023
FY 31/12/2023
2024
FY 31/12/2024
2025
FY 31/12/2025
Revenue66,90570,98677,084
EBITDA———
Attributable net income1,5784,4263,379
Free cash flow———
Net debt-1,174-877-2,703

Each fiscal year is labelled with the calendar year in which most of its months fall.

The scores summarise metrics compared with similar companies, and the alerts point to specific facts. Nothing shown here is a recommendation to buy or sell.